Видео ютуба по тегу Gw Pharma

Jim Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 billion
Jim Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 billion
Jazz Pharmaceuticals buys GW Pharma for $7.2 billion
Jazz Pharmaceuticals buys GW Pharma for $7.2 billion
GW Pharmaceuticals market stock research📈, should we buy $GWPH?
GW Pharmaceuticals market stock research📈, should we buy $GWPH?
GW Pharma CEO explains company's plan for CBD-based epilepsy drug
GW Pharma CEO explains company's plan for CBD-based epilepsy drug
GW Pharma CEO on new cannabis-derived drug
GW Pharma CEO on new cannabis-derived drug
Canaccord Genuity initiated coverage on GW Pharmaceuticals NASDAQ GWPH
Canaccord Genuity initiated coverage on GW Pharmaceuticals NASDAQ GWPH
GW Pharma CEO talks Epidiolex sales amid the pandemic
GW Pharma CEO talks Epidiolex sales amid the pandemic
GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC
GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC
GW Pharma CEO: Need to know more on benefits of cannabis-derived drugs
GW Pharma CEO: Need to know more on benefits of cannabis-derived drugs
Epidiolex sales, potential CBD treatment for PTSD and more: GW Pharma CEO
Epidiolex sales, potential CBD treatment for PTSD and more: GW Pharma CEO
GW Pharmaceuticals Fly through
GW Pharmaceuticals Fly through
Jazz Pharmaceuticals' acquisition of GW Pharmaceuticals for $7.2bn
Jazz Pharmaceuticals' acquisition of GW Pharmaceuticals for $7.2bn
GW Pharmaceuticals
GW Pharmaceuticals
GW Pharmaceuticals CEO: Pot Play | Mad Money | CNBC
GW Pharmaceuticals CEO: Pot Play | Mad Money | CNBC
Jim Cramer on Pot - GW Pharma
Jim Cramer on Pot - GW Pharma
GW Pharmaceuticals CEO: Defining CBD and THC-based Drugs | Mad Money | CNBC
GW Pharmaceuticals CEO: Defining CBD and THC-based Drugs | Mad Money | CNBC
GW Pharmaceuticals CEO: A ‘Big Step’ Forward | Mad Money | CNBC
GW Pharmaceuticals CEO: A ‘Big Step’ Forward | Mad Money | CNBC
GW Pharma lobbyist vs hemp
GW Pharma lobbyist vs hemp